Press Releases
IAVI Announces Launch of EDCTP-funded Socio-behavioral Project on Accessible HIV Prevention Tools for African Women
October 29, 2020IAVI Announces Start of Clinical Trial of Next-Generation HIV Vaccine Candidate
October 27, 2020Support from the U.S. Department of Defense Will Accelerate Progress on Vaccine Candidate for COVID-19, IAVI Says
October 22, 2020IAVI, Merck KGaA, Darmstadt, Germany, and Serum Institute of India Join Forces to Develop Monoclonal Antibodies for COVID-19 and Ensure Prompt and Equitable Global Access
August 10, 2020IAVI and Wellcome issue a global call to action: Monoclonal antibodies for COVID-19 and other diseases could save millions of lives
Features
TB vaccine candidate being investigated to prevent TB infection in infants in Phase III priMe study
January 19, 2021IAVI at HIVR4P Virtual 2021
December 7, 2020Donor Spotlight: European & Developing Countries Clinical Trials Partnership
December 1, 2020HIV Activist Winifred Ikilai: 5 Things to Know on World AIDS Day 2020
November 9, 2020Study finds long-acting injectable HIV prevention option is effective for cisgender women
Media Contacts
North America
Rose Catlos
+1 212 847 1049
RCatlos@iavi.org